methallenestril

RN given refers to parent cpd

Also Known As:

Vallestril; methallenestril, (+)-isomer; methallenestril, (+-)-isomer; methallenestril, (-)-isomer; beta-ethyl-6-methoxy-alpha,alpha-dimethyl-2- naphthalenepropionic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        methallenestril: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - methallenestril: 1

Related Diseases

1.	Primary Hyperparathyroidism 01/01/1983 - "Methallenestril was administered in a dose of 6 mg daily to 6 postmenopausal women with hypercalcaemia and primary hyperparathyroidism (HPT) for periods between 5 and 24 weeks. " 01/01/1983 - "Normalization of hypercalcaemia of primary hyperparathyroidism by treatment with methallenestril, a synthetic oestrogen with low oestrogenicity."